证券代码：603717 证券简称：天域生物 公告编号：2025-074 天域生物科技股份有限公司 关于公司 2025 年半年度募集资金存放与实际使用情况 的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、募集资金基本情况 （一）实际募集资金金额、资金到位时间 经中国证券监督管理委员会出具的《关于核准天域生态环境股份有限公司非 公开发行股票的批复》（证监许可[2021]101 号），天域生物科技股份有限公司 （以下简称"公司"，曾用名"天域生态环境股份有限公司"）向特定对象发行 人民币普通股（A 股）股票 4,835 万股，每股发行价格为人民币 8.32 元，本次非 公开发行股票募集资金总额为人民币 402,272,000.00 元，扣除不含税各项发行费 用人民币 8,406,457.62 元，本次非公开发行股票募集资金净额为人民币 393,865,542.38 元。众华会计师事务所（特殊普通合伙）已于 2021 年 06 月 22 日对公司本次非公开发行 A 股股票的资金到位情况进行了审验，并出具了"众 会字（2 ...

证券代码：603717 证券简称：天域生物 公告编号：2025-075 天域生物科技股份有限公司 关于 2024 年度"提质增效强回报"行动方案 一、聚焦主业、加快业务转型，持续提升经营效率 公司始终坚持"稳中求进"的经营策略，深耕主业发展，持续推动经营效率 稳步提升。2024年度，公司实现营业收入80,150.67万元，较去年同期增长19.55%， 实现归属于上市公司股东净利润大幅减亏；其中生猪养殖业务营业收入 57,937.49 万元，占比 72.29%，较上年同期增长 15.81%。 2025 年上半年，公司继续紧抓主业发展，探索"数智化"转型升级，提升 公司竞争力，推动公司高质量发展。在生猪养殖业务方面，公司积极推动产能优 化，合理调整猪场生产模式和结构，提高猪场产能利用率；并按计划推进与高校 1 之间的产学研合作项目，对生猪产业链关键环节开展课题研究，加快实践转化， 帮助提升养殖效率，探索建立智能化养殖体系，赋能公司业务高质量发展。2025 年上半年，公司实现营业收入 41,230.30 万元，同比减少 2.62%；实现归属于上 市公司股东的净利润 1,081.80 万元，同比增长 73.68%。其 ...

证券代码：603717 证券简称：天域生物 公告编号：2025-076 天域生物科技股份有限公司 关于召开 2025 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 会议召开方式：上证路演中心网络互动 投资者可于 2025 年 09 月 03 日 （星期三） 至 09 月 09 日（星期二）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 IR@tygf.cn 进行提问。公司将在说明会上对投资者普遍关注的问题进行回答。 天域生物科技股份有限公司（以下简称"公司"）已于 2025 年 08 月 30 日发 布公司《2025 年半年度报告》，为便于广大投资者更全面深入地了解公司 2025 年 半年度经营成果、财务状况，公司计划于 2025 年 09 月 10 日（星期三）13:00-14:00 举行 2025 年半年度业绩说明会，就投资者关心的问题进行交流。 一、说明会类型 本次投资者说明会以网络互动形式召开，公司将针对 2025 年半年度的经营成 果及财务指标的具体情况与投资者 ...

Core Insights - Tianyu Bio reported a closing price of 8.31 yuan on August 27, down 6.52% from the previous trading day [1] - The company has a total market capitalization of 2.41 billion yuan and a price-to-earnings ratio of 43.78 times [1] Business Overview - The company's main business segments include ecological agriculture and animal husbandry, ecological energy, and ecological environment, covering areas such as pig farming, distributed photovoltaic power stations, and landscape ecological engineering [1] - The company forecasts a net profit of 8 million to 12 million yuan for the first half of 2025, representing a year-on-year growth of 28.44% to 92.66% [1] Shareholder Changes - On August 26, the company announced a change in its actual controller, with the original co-controller Shi Dongwei retiring for personal reasons, leaving Luo Weiguo as the sole actual controller [1] Fundraising and Debt - The company disclosed a private placement plan to issue no more than 71.03 million shares to enterprises controlled by the actual controller, raising 465 million yuan for working capital and debt repayment [1] - As of the announcement date, the total amount of external guarantees provided by the company and its subsidiaries reached 1.116 billion yuan, accounting for 215.21% of the most recent audited net assets [1] Capital Flow - On August 27, the net outflow of main funds was 36.18 million yuan, representing 1.5% of the circulating market value [1] - Over the past five trading days, the cumulative net inflow of main funds was 18.44 million yuan, accounting for 0.76% of the circulating market value [1]

Core Viewpoint - Tianyu Biological announced the signing of a feed purchase and sales contract with suppliers, effective until August 2026, indicating a strategic move to secure supply chains and enhance operational stability [1] Summary by Relevant Sections Contract Details - The contract signed by Tianyu Biological's subsidiary Tianqian Food and its affiliates is a feed purchase and sales agreement, valid until August 2026 [1] - The company has also entered into a maximum guarantee contract, providing joint liability for all debts incurred under the feed purchase contract, with a maximum guarantee limit of RMB 3 million [1] Financial Implications - The guarantee period for the debts is set for two years, starting from the maturity date of the guaranteed debts [1] - As of the date of the announcement, the total amount of external guarantees provided by the company and its subsidiaries is RMB 1,116.40 million, which represents 215.21% of the company's most recent audited net assets [1]

证券代码：603717 证券简称：天域生物 公告编号：2025-071 天域生物科技股份有限公司 关于公司 2025 年度对外担保预计的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | | 被担保人名称 | 天乾食品有限公司（以下简称"天 乾食品"） | | | | --- | --- | --- | --- | --- | | | | 宜都天乾农牧有限公司麻城分公司 | | | | | | （以下简称"宜都天乾麻城分"） | | | | | 本次担保金额 | 300.00 | 万元 | | | 担保对象 | 实际为其提供的担保余额 | 1,000.00 万元（天乾食品） | | | | | | 万元（宜都天乾麻城分） 627.08 | | | | | 是否在前期预计额度内 | 是 | □否 | □不适用：_________ | | | 本次担保是否有反担保 | □是 | 否 | □不适用：_________ | 担保对象及基本情况 累计担保情况 | 对外担保逾期的累计金额（万元） | / | ...

Market Overview - The aquaculture sector experienced a decline of 1.63% on August 27, with Tianyu Biological leading the drop [1] - The Shanghai Composite Index closed at 3800.35, down 1.76%, while the Shenzhen Component Index closed at 12295.07, down 1.43% [1] Stock Performance - Notable stock performances in the aquaculture sector include: - Zhengbang Technology (002157) closed at 3.04, up 1.67% with a trading volume of 4.3755 million shares and a turnover of 1.363 billion yuan [1] - Tianyu Biological (603717) closed at 8.31, down 6.52% with a trading volume of 228,400 shares and a turnover of 196 million yuan [2] - Other significant declines include: - Xinnong (000876) down 1.56% to 10.12 [1] - Wens Foodstuff (300498) down 2.00% to 18.11 [1] Capital Flow - The aquaculture sector saw a net outflow of 921 million yuan from institutional investors, while retail investors had a net inflow of 459 million yuan [2] - The capital flow for specific stocks indicates: - Huaying Agriculture (002321) had a net inflow of 21.13 million yuan from institutional investors [3] - ST Tianshan (300313) experienced a significant net outflow of 8.74 million yuan from institutional investors [3]

中国经济网北京8月27日讯天域生物（603717）(603717.SH)昨晚披露2025年度向特定对象发行A股股票预案，本次向特定对象发行股票的发 行对象为公司实际控制人罗卫国控制的导云资产。本次发行对象以现金方式认购本次发行的股票。 经双方协商一致，发行价格确定为6.55元/股，不低于定价基准日前20个交易日公司股票交易均价的80%。 本次向特定对象发行股票的种类为境内上市的人民币普通股(A股)，每股面值为人民币1.00元。本次向特定对象发行的股票在锁定期届满 后，在上海证券交易所上市交易。本次向特定对象发行A股股票数量确定为不超过71,028,297股(含本数)，发行股票数量的上限不超过本次发 行前公司总股本的30%。 本次募集资金总额不超过人民币46,523.53万元(含本数)，募集资金在扣除相关发行费用后将全部用于补充流动资金和偿还债务。 本次发行前，罗卫国持有公司12.84%股权，系公司实际控制人。本次认购对象为实际控制人罗卫国控制的导云资产，按本次股票发行上限 计算，发行完成后，罗卫国将控制公司29.98%股份表决权，依然为公司实际控制人，本次发行不会导致公司控制权发生变化。 罗卫国持有导云资产9 ...

Key Points - The article highlights significant corporate announcements and performance metrics from various companies in the industry [1][2][3][4] Group 1: Corporate Announcements - Sente Co., Ltd. (森特股份) clarified that it does not engage in "data center" related businesses [1] - Inke Recycling (英科再生) plans to invest approximately $40 million in the construction of the Vietnam Inke Qinghua (Phase III) project [1] - Daikin Heavy Industries (大金重工) signed its first overseas contract for the construction of a heavy deck transport vessel [1] - Zancaiya (咱菜雅) is planning to issue H-shares [1] - Biyimi (必易微) intends to acquire 100% equity of Xingan Semiconductor for 295 million yuan [1] - Zhongheng Group (中恒集团) has repurchased 3.5649% of its shares [1] - Nanjing New Pharmaceutical (南新制药) signed a letter of intent for acquisition with Future Pharmaceutical [3] - Pan-Asia Microelectronics (泛亚微透) plans to raise no more than 699 million yuan through a private placement [1][4] Group 2: Financial Performance - Shenghong Technology (胜宏科技) reported a net profit of 2.143 billion yuan for the first half of the year, a year-on-year increase of 366.89% [2] - Zhongji Xuchuang (中际旭创) saw a year-on-year net profit increase of 69.4% and plans to distribute 4 yuan per 10 shares [2] - Cambrian (寒武纪) achieved a net profit of 1.038 billion yuan in the first half of the year, marking a turnaround from losses [2] - China National Petroleum Corporation (中国石油) reported a net profit of 84.01 billion yuan for the first half of the year [2] Group 3: Shareholding Changes - Several companies, including Xindong Lian Ke (芯动联科) and Shenkeda (深科达), announced plans for share reductions by major shareholders [4] - Chaoyang Technology (朝阳科技) and Zhongwei Company (中微公司) also plan to reduce their shareholdings by up to 3% and 2%, respectively [4]

Core Viewpoint - Tianyu Biotechnology Co., Ltd. is issuing A-shares to specific investors, which will dilute immediate returns and affect key financial metrics, but the company has outlined measures to mitigate this impact [1][2][8]. Financial Impact Analysis - The issuance will increase the total share capital from 29,014.62 million shares to 36,117.45 million shares [5]. - The net profit attributable to shareholders, excluding non-recurring gains and losses, is projected to be -113.14 million yuan for 2024, with three scenarios for 2025: flat, 10% growth, and 20% growth [2][6]. - Under the flat scenario, basic and diluted earnings per share (EPS) will remain at -0.37 yuan, while under the 10% growth scenario, EPS will improve to -0.33 yuan [6]. - In the 20% growth scenario, EPS is projected to reach -0.30 yuan [6]. Necessity and Feasibility of the Issuance - The funds raised will be used to enhance liquidity and repay debts, improving the company's financial structure and risk resilience [8]. - The issuance aligns with the company's long-term development goals and shareholder interests [8]. Measures to Mitigate Dilution of Immediate Returns - The company plans to enhance governance structures to protect shareholder rights and ensure effective decision-making [9]. - It will implement strict management of raised funds to ensure efficient use and compliance with regulations [9]. - A profit distribution system will be established to ensure reasonable returns to shareholders, with a three-year shareholder return plan from 2025 to 2027 [11]. Commitments from Company Leadership - The actual controller and senior management have made commitments to ensure the effectiveness of measures to mitigate the dilution of immediate returns [12][12].